Author |
Title |
JournalName |
Year D |
Click on Column Headers to Re-Sort The Current List |
LEIN OG, SHULGIN AT, GAL ... |
Feasibility of quantitative separation of the threo- and erythro-forms... |
Nature |
1952 |
Shulgin AT |
Psychotomimetic amphetamines: methoxy 3,4-dialkoxyamphetamines |
Experientia |
1964 |
Naranjo C, Shulgin AT, Sa... |
Evaluation of 3,4-methylenedioxyamphetamine MDA as an adjunct to psych... |
Med Pharmacol Exp In... |
1967 |
Shulgin AT, Sargent T, Na... |
The chemistry and psychopharmacology of nutmeg and of several related ... |
Psychopharmacol Bull |
1967 |
Shulgin AT, Sargent T, Na... |
Structure--activity relationships of one-ring psychotomimetics |
Nature |
1969 |
Antun F, Smythies JR, Ben... |
Native Fluorescence and Hallucinogenic Potency of Some Amphetamines |
Experientia |
1971 |
Shulgin AT |
Mescaline: the chemistry and pharmacology of its analogs |
Lloydia |
1973 |
Shulgin AT |
Sterospecific requirements for hallucinogenesis |
J. Pharm. Pharmacol. |
1973 |
Shulgin AT, Carter MF |
Centrally Active Phenethylamines |
Psychopharmacology C... |
1975 |
Shulgin AT, Helisten C |
Differentiation of PCP, TCP, and a contaminating precursor PCC, by thi... |
Microgram |
1975 |
Shulgin, A. |
Profiles of Psychedelic Drugs: TMA-2 |
Journal of Psychoact... |
1976 |
Shulgin, AT |
Profiles of Psychedelic Drugs: DMT |
Journal of Psychedel... |
1976 |
Shulgin, A. |
Profiles of Psychedelic Drugs: MMDA |
Journal of Psychoact... |
1976 |
Shulgin, A. |
Profiles of Psychedelic Drugs: STP |
Journal of Psychoact... |
1977 |
Braun U, Shulgin AT, Brau... |
Synthesis and Body Distribution of Several Iodine-131 Labeled Centrall... |
Journal of Medicinal... |
1977 |
Anderson GM 3d, Braun G, ... |
Absolute configuration and psychotomimetic activity |
NIDA Res Monogr |
1978 |
Shulgin AT, Nichols DE |
Characterization of three new psychotomimetics. The Pharmacology of Ha... |
The Psychopharmacolo... |
1978 |
Braun U, Braun G, Jacob P... |
Mescaline analogs: substitutions at the 4-position |
NIDA Res Monogr |
1978 |
Murdock JE, Shulgin AT |
A novel illicit amphetamine laboratory |
Microgram |
1978 |
Shulgin AT |
Chemistry of phenethylamines related to mescaline |
J Psychedelic Drugs |
1979 |
Carter MF, Shulgin AT |
N,N-Diisopropyltryptamine (DIPT) and 5-methoxy-N,N-diisopropyltryptami... |
Commun Psychopharmac... |
1980 |
Braun U, Shulgin AT, Brau... |
Centrally active N-substituted analogs of 3,4- methylenedioxyphenyliso... |
J Pharm Sci |
1980 |
Shulgin, A. |
Profiles of Psychedelic Drugs: Bufotenine |
Journal of Psychoact... |
1981 |
Domelsmith LN, Eaton TA, ... |
Photoelectron spectra of psychotropic drugs. 6. Relationships between ... |
J Med Chem |
1981 |
Cassels BK, Gómez-Jeria J... |
A reevaluation of psychotomimetic amphetamine derivatives in humans |
J Psychoactive Drugs |
1985 |
Repke DB, Grotjahn DB, Sh... |
Psychotomimetic N-methyl-N-isopropyltryptamines. Effects of variation ... |
J Med Chem |
1985 |
Lemaire D, Jacob P, Shulg... |
Ring-substituted beta-methoxyphenethylamines: a new class of psychotom... |
J Pharm Pharmacol |
1985 |
Shulgin AT, Shulgin LA, J... |
A protocol for the evaluation of new psychoactive drugs in man |
Methods Find Exp Cli... |
1986 |
Greer G, Tolbert R |
Subjective reports of the effects of MDMA in a clinical setting |
J Psychoactive Drugs |
1986 |
Shulgin AT |
The background and chemistry of MDMA |
J Psychoactive Drugs |
1986 |
Siegel RK |
MDMA-Nonmedical use and intoxication |
J Psychoactive Drugs |
1986 |
Nichols DE, Hoffman AJ, O... |
Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives ... |
J Med Chem |
1986 |
Shulgina GI |
On neurotransmitter mechanisms of reinforcement and internal inhibitio... |
Pavlov J Biol Sci |
1986 |
Cozzi NV, Sievert MK, Shu... |
Methcathinone and 2-methylamino-1-(3,4-methylenedioxyphenyl)propan-1-o... |
Soc. Neurosci. Abs |
1988 |
McKenna DJ, Guan XM, Shul... |
3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential eff... |
Pharmacol Biochem Be... |
1991 |
Stolaroff MJ, Wells CW |
Preliminary Results with New Psychoactive Agents 2C-T-2 AND 2C-T-7 |
Yearbook for Ethnome... |
1993 |
Hastings A |
Some observations on MDMA experiences induced through posthypnotic sug... |
J Psychoactive Drugs |
1994 |
Jacob P III, Shulgin A |
Structure-Activity Relationships of the Classic Hallucinogens and Thei... |
NIDA Research Monogr... |
1994 |
Galloway G, Shulgin AT, K... |
Amphetamine, not MDMA, is associated with intracranial hemorrhage |
J Accid Emerg Med |
1995 |
Shulgin A |
The new psychotherapy: MDMA and the shadow |
Eleusis |
1995 |
Parker MA, Marona-Lewicka... |
Synthesis and pharmacological evaluation of ring-methylated derivative... |
J Med Chem |
1998 |
Cozzi NV, Shulgin AT, Ruo... |
Methcathinone (MCAT) and 2-methylamino-1-(3,4-methylenedioxyphenyl)pro... |
Amer. Chem. Soc. Div... |
1998 |
Cozzi NV, Sievert MK, Shu... |
Inhibition of plasma membrane monoamine transporters by beta-ketoamphe... |
Eur J Pharmacol |
1999 |
Boire RG, Patchen JD |
NOTES ON THE SCHEDULING OF CATHINONE, CATHINE, AND THE PLANT CATHAEDUL... |
private e-mail legal... |
1999 |
Callaway JC, Grob CS, McK... |
A demand for clarity regarding a case report on the ingestion of 5-met... |
J Anal Toxicol |
2006 |
Benzenhöfer U, Passie T |
Rediscovering MDMA ecstasy: the role of the American chemist Alexander... |
Addiction |
2010 |
Cozzi NV, Daley PF |
Receptor binding profiles and quantitative structure-affinity relation... |
Bioorganic & Medicin... |
2015 |
Passie T, Benzenhöfer U |
The History of MDMA as an Underground Drug in the United States, 1960-... |
J Psychoactive Drugs |
2016 |